Cullinan Therapeutics, Inc.
NASDAQCullinan Therapeutics heads into its June 16 earnings event with options traders the most defensively positioned they have been in months, even as short sellers quietly trimmed exposure this week. The options signal is the sharpest read in the data right now. The put/call ratio climbed to 0.78 on Tuesday — more than two standard deviations above its 20-day average of 0.56. That…
Snapshot as of 11 Jun 2026
Cullinan Therapeutics heads into its June 16 earnings event with options traders the most defensively positioned they have been in months, even as short sellers quietly trimmed exposure this week. The options signal is…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CGEM — free to start on ORTEX.
Sign up for free →Open CGEM on ORTEX